Quantitation of estrogen receptor mRNA in breast carcinoma by branched DNA assay.
A quantitative nucleic acid hybridization assay for determination of estrogen receptor (ER) mRNA in breast carcinoma is described. The assay, which is based on the branched DNA (bDNA) technology, requires 20 mg of tissue, is simple, highly specific, and reproducible, and correlates reasonably well with an established methodology (r = 0.87). The assay has a dynamic range of 3 x 10(3)-6 x 10(7) copies of ER mRNA per well. ER message as high as 2.5 x 10(6) copies per well could be detected in normal breast tissues. Thus a sensitivity of 3 x 10(3) ER copies per well was sufficient to analyze clinical specimens. In the present studies, accurate measurement of tissue weight enabled direct reporting of the ER mRNA values as the end point results. The bDNA assay provides a useful tool for the detection and quantitation of ER mRNA in research and routine clinical laboratories.
Nargessi
R D
RD
Chiron Diagnostics, Alameda, California, USA. dnargessi@hotmail.com
Khabbaz
N F
NF
Xu
X M
XM
Zamroud
M
M
Kolberg
J
J
Collins
M L
ML
D000818:Animals; D001943:Breast Neoplasms / Q000737:chemistry* / Q000235:genetics; D006224:Cricetinae; D015342:DNA Probes; D004273:DNA, Neoplasm / Q000032:analysis; D005260:Female; D006801:Humans; D015674:Mammary Neoplasms, Animal / Q000737:chemistry* / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis*; D012334:RNA, Neoplasm / Q000032:analysis*; D011960:Receptors, Estrogen / Q000032:analysis* / Q000235:genetics; D012680:Sensitivity and Specificity; D014407:Tumor Cells, Cultured
D015342:DNA Probes; D004273:DNA, Neoplasm; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D011960:Receptors, Estrogen